Dyrnamix Discovery Engine
We develop novel biomarkers that have an immediate impact on patient care and allow physicians and industry to tailor existing and new interventions for their patients with cardiovascular disease
Integrating genomic technology and bioinformatics
The Dyrnamix team employs sophisticated plasma exRNA extraction/identification techniques married with big data analytics to develop an advanced platform for extracellular RNA identification, analysis and discovery of non-invasive biomarkers in cardiovascular disease.
